Comparative Effectiveness of Anti-TNF in Combination With Low-Dose Methotrexate vs Anti-TNF Monotherapy in Pediatric Crohn's Disease: A Pragmatic Randomized Trial

Michael D. Kappelman, David A. Wohl, Hans H. Herfarth, Ann M. Firestine, Jeremy Adler, Rana F. Ammoury, Jeanine E. Aronow, Dorsey M. Bass, Julie A. Bass, Keith Benkov, Catalina Berenblum Tobi, Margie E. Boccieri, Brendan M. Boyle, William B. Brinkman, Jose M. Cabera, Kelly Chun, Richard B. Colletti, Cassandra M. Dodds, Jill M. Dorsey, Dawn R. EbachEdurne Entrena, Christopher B. Forrest, Joseph A. Galanko, John E. Grunow, Ajay S. Gulati, Anastasia Ivanova, Traci W. Jester, Jess L. Kaplan, Subra Kugathasan, Mark E. Kusek, Ian H. Leibowitz, Tiffany M. Linville, Ellen A. Lipstein, Peter A. Margolis, Phillip Minar, Zarela Molle-Rios, Jonathan Moses, Kelly K. Olano, Lourdes Osaba, Pablo J. Palomo, Helen Pappa, K. T. Park, Dinesh S. Pashankar, Lisa Pitch, Michelle Robinson, Charles M. Samson, Kelly C. Sandberg, Julia R. Schuchard, Michael Seid, Kimberly A. Shelly, Steven J. Steiner, Jennifer A. Strople, Jillian S. Sullivan, Jeanne Tung, Prateek Wali, Michael Zikry, Morris Weinberger, Shehzad A. Saeed, Athos Bousvaros

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)149-161.e7
JournalGastroenterology
Volume165
Issue number1
DOIs
StatePublished - Jul 2023
Externally publishedYes

ASJC Scopus Subject Areas

  • Hepatology
  • Gastroenterology

Keywords

  • Adalimumab
  • Anti-Tumor Necrosis Factor–α
  • Children
  • Crohn's Disease
  • Infliximab
  • Methotrexate

Cite this